Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction
about
The biological and clinical significance of MLL abnormalities in haematological malignancies.Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia.Tumor heterogeneity makes AML a "moving target" for detection of residual disease.Establishment of a nude mice model of human monocytic leukemia with CNS and multiorgan extramedullary infiltration.
P2860
Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Monitoring of minimal residual ...... tase polymerase chain reaction
@en
Monitoring of minimal residual ...... tase polymerase chain reaction
@nl
type
label
Monitoring of minimal residual ...... tase polymerase chain reaction
@en
Monitoring of minimal residual ...... tase polymerase chain reaction
@nl
prefLabel
Monitoring of minimal residual ...... tase polymerase chain reaction
@en
Monitoring of minimal residual ...... tase polymerase chain reaction
@nl
P2093
P2860
P1476
Monitoring of minimal residual ...... tase polymerase chain reaction
@en
P2093
G Mitterbauer
H Pirc-Danoewinata
I Schwarzinger
P2860
P304
P356
10.1046/J.1365-2141.2000.02076.X
P407
P577
2000-06-01T00:00:00Z